{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:33:10Z","timestamp":1769603590384,"version":"3.49.0"},"reference-count":53,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2023,8,22]]},"DOI":"10.1167\/tvst.12.8.17","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:30:54Z","timestamp":1692714654000},"page":"17","source":"Crossref","is-referenced-by-count":5,"title":["Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm \u2013 A Randomized Pilot Study"],"prefix":"10.1167","volume":"12","author":[{"given":"Rona Z.","family":"Silkiss","sequence":"first","affiliation":[{"name":"Silkiss Eye Surgery, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayson","family":"Koppinger","sequence":"additional","affiliation":[{"name":"VA Sierra Nevada Health Care System, Reno, NV, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Truong","sequence":"additional","affiliation":[{"name":"The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gibson","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Tyler","sequence":"additional","affiliation":[{"name":"Smith-Kettlewell Eye Research Institute, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"issue":"Pt 3","key":"bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/108.3.593","article-title":"Pathophysiology of blepharospasm and oromandibular dystonia","volume":"108","author":"Berardelli","year":"1985","journal-title":"Brain"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1468-1331.2009.02840.x","article-title":"Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm","volume":"17","author":"Conte","year":"2010","journal-title":"Eur J Neurol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1523\/JNEUROSCI.3948-05.2006","article-title":"Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm","volume":"26","author":"Quartarone","year":"2006","journal-title":"J Neurosci"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/jnnp.2009.178236","article-title":"Somatosensory temporal discrimination in patients with primary focal dystonia","volume":"80","author":"Scontrini","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves","year":"2012","journal-title":"Mov Disord"},{"key":"bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mds.870100406","article-title":"Prevalence of focal dystonias in the western area of Tottori prefecture in Japan","volume":"4","author":"Nakashima","year":"1995","journal-title":"Mov Disord"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s004150070094","article-title":"A prevalence study of primary dystonia in eight European countries","volume":"247","author":"Epidemiological Study of Dystonia in Europe Collaborative Group","year":"2000","journal-title":"J Neurol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1212\/WNL.56.11.1579","article-title":"Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy","volume":"56","author":"Defazio","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"bib10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archneur.1986.00520040060020","article-title":"Botulinum toxin in the management of blepharospasm","volume":"43","author":"Dutton","year":"1986","journal-title":"EG Arch Neurol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum a toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","article-title":"Blepharospasm: past, present, and future","volume":"14","author":"Anderson","year":"1998","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.iio.0000167238.26526.a8","article-title":"Benign essential blepharospasm","volume":"45","author":"Simon","year":"2005","journal-title":"Int Ophthalmol Clin"},{"issue":"12","key":"bib14","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3390\/pharmaceutics14122598","article-title":"Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020-2022)","volume":"14","author":"Souza","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"bib15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/14737175.2023.2195551","article-title":"Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry","volume":"23","author":"Tait","year":"2023","journal-title":"Expert Rev Neurother."},{"issue":"6","key":"bib16","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano","year":"2022","journal-title":"Int J Molec Sci"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11864-022-01047-y","article-title":"Therapeutic and supportive effects of cannabinoids in patients with brain tumors (CBD oil and cannabis)","volume":"24","author":"Rodriguez-Almaraz","year":"2023","journal-title":"Curr Treatment Options in Oncol"},{"issue":"5","key":"bib18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01658107.2017.1318150","article-title":"Medical cannabis, a beneficial high in treatment of blepharospasm? An early observation","volume":"41","author":"Radke","year":"2017","journal-title":"Neuroophthalmology"},{"issue":"5","key":"bib19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00417-021-05533-1","article-title":"Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study","volume":"260","author":"Zloto","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"1407","key":"bib21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signaling","volume":"356","author":"Elphick","year":"2001","journal-title":"Philos Trans Roy Soc Lond. B Biol Sci"},{"issue":"5746","key":"bib22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Brit J Pharmacol"},{"issue":"20","key":"bib25","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Brit J Pharmacol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/NMM:7:1-2","article-title":"Cannabinoid receptors and their role in neuroprotection","volume":"7","author":"Van der Stelt","year":"2005","journal-title":"Neuromol Med"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/187152707783399210","article-title":"Cannabinoids and neuroprotection in motor-related disorders","volume":"6","author":"De Lago","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clim.2011.02.010","article-title":"Neuroprotective agents: cannabinoids","volume":"142","author":"S\u00e1nchez","year":"2012","journal-title":"Clin Immunol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1358\/dot.2006.42.8.1021517","article-title":"Combined cannabinoid therapy via an oromucosal spray","volume":"42","author":"Perez","year":"2006","journal-title":"Drugs Today"},{"issue":"6","key":"bib31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"bib32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.ophtha.2018.03.013","article-title":"Chemodenervation for the treatment of facial dystonia: a report by the American Academy of Ophthalmology","volume":"125","author":"Bilyk","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"bib33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0733-8635(03)00019-6","article-title":"Development of botulinum toxin therapy","volume":"22","author":"Scott","year":"2004","journal-title":"Dermatol Clin"},{"issue":"1\u20132","key":"bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neurol.2020.03.022","article-title":"Botulinum toxin for benign essential blepharospasm: a systematic review and an algorithmic approach","volume":"177","author":"Rayess","year":"2021","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"bib35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/jnnp.60.6.693-a","article-title":"Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients","volume":"60","author":"Albanese","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"bib36","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1007\/s00415-022-10995-2","article-title":"Time to onset and duration of botulinum toxin efficacy in movement disorders","volume":"269","author":"Ledda","year":"2022 Jul","journal-title":"J Neurol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.yebeh.2020.107452","article-title":"Current legal status of medical marijuana and cannabidiol in the United States","volume":"112","author":"Alharbi","year":"2020","journal-title":"Epilepsy Behav"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/mds.25579","article-title":"Dystonia rating scales: critique and recommendations","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/mds.v18:3","article-title":"Dystonia Study Group. Rating scales for dystonia: a multicenter assessment","volume":"18","author":"Comella","year":"2003","journal-title":"Mov Disord"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/mds.26156","article-title":"Development and validation of a clinical scale for rating the severity of blepharospasm","volume":"30","author":"Defazio","year":"2015","journal-title":"Mov Disord"},{"issue":"7","key":"bib44","first-page":"608","article-title":"Do blinking parameters in essential blepharospasm patients become similar to normal subjects after botulinum toxin injections?","volume":"63","author":"Gustavo","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/jnnp.52.4.477","article-title":"The relationship between eye-winking tics, frequent eye-blinking and blepharospasm","volume":"52","author":"Elston","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"bib46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajo.2006.02.020","article-title":"The evaluation of light sensitivity in benign essential blepharospasm","volume":"142","author":"Adams","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"bib47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/01658100701247646","article-title":"Shedding light on Blepharospasm: a patient\u2013researcher partnership approach to assessment of photophobia and impact on activities of daily living","volume":"31","author":"Judd","year":"2009","journal-title":"Neuro-Ophthalmology"},{"issue":"3","key":"bib48","first-page":"2011","article-title":"Clinical features of patients with Blepharospasm: a report of 240 cases","volume":"18","author":"Peckham","journal-title":"Eur J of Neurology"},{"issue":"12","key":"bib49","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.ophtha.2005.06.030","article-title":"Modulation of sensory photophobia in essential blepharospasm with chromatic lenses","volume":"112","author":"Herz","year":"2005","journal-title":"Ophthalmology"},{"issue":"21","key":"bib50","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"New Engl J Med"},{"issue":"20","key":"bib51","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"bib7","first-page":"121","article-title":"The epidemiology of primary dystonias in the North of England","volume-title":"Dystonia 3, Advances in Neurology","author":"Duffey","year":"1998"},{"key":"bib37","article-title":"Title 21 - Food and Drugs. Chapter 13 - Drug Abuse Prevention and Control. Subchapter I - Control and Enforcement","author":"1 U.S.C. United States Code, 2014 Edition"},{"key":"bib52","author":"Epidiolex (cannabidiol oral solution \u2013 Accessdata.fda"},{"key":"bib53","volume-title":"Project Green","author":"Koppinger","year":"2018"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2791424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:30:59Z","timestamp":1692714659000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2791424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.12.8.17","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}